In a first, FDA approved Sarepta gene therapy for Duchenne muscular dystrophy : Shots
The Food and Drug Administration approved the first gene therapy to treat the most common form of muscular dystrophy. Sarah Silbiger/Getty Images hide caption toggle captions Sarah Silbiger/Getty Images In an eagerly anticipated decision, the Food and Drug Administration Thursday approved the first gene therapy for muscular dystrophy. “Today’s approval addresses an urgent unmet medical …
In a first, FDA approved Sarepta gene therapy for Duchenne muscular dystrophy : Shots Read More »